LENZ Therapeutics Inc
LENZKey Statistics
Open
$8.21
Day High
$8.49
Day Low
$7.75
Prev. Close
$7.99
VolumeShares traded today.
765.41K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$243.94M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-2.16
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$50.40
52W LowLowest price over the past 52 weeks.
$6.61
50D MAAverage closing price over the last 50 trading days.
$9.02
200D MAAverage closing price over the last 200 trading days.
$22.30
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+3.5%1M
-14.0%6M
-74.0%YTD
-51.4%1Y
-73.3%About
Aceclidine is a parasympathomimetic cholinergic drug that functions as a muscarinic acetylcholine receptor agonist. It is used in ophthalmology as a miotic agent to constrict the pupil. Historically used in Europe for the treatment of glaucoma, aceclidine received its first U.S. approval in 2025 under the brand name Vizz as a topical eye drop for the correction of presbyopia. Its mechanism of action produces pupil contraction with a relatively minimal effect on the ciliary muscle, which improves near visual acuity through a "pinhole" depth-of-field effect without inducing significant accommodative spasm.
Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade LENZ
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.